LP:As a passive LP, a family office could commit to a life science fund managed by a reputable sponsor to gain exposure without direct management responsibilities.

LP:Family offices can also consider passive LP commitments in established funds focused on the Boston life sciences sector.

LP:The passive LP angle for a family office may involve committing to funds focused on life sciences, though this approach may carry higher risk given the current vacancy trends.

LP:Family offices may also consider passive LP commitments in established life sciences funds to gain exposure without direct management responsibilities.

LP:As a passive LP, a family office could commit to funds targeting established life sciences operators, though this approach offers less influence over asset selection.

LP:The passive LP angle for a family office would involve committing capital to a life sciences fund managed by a reputable sponsor.

LP:The passive LP angle for a family office would involve committing capital to a life sciences-focused fund managed by an experienced sponsor.

LP:As a passive LP, a family office could commit capital to a fund focused on Raleigh life sciences, gaining exposure without direct management responsibilities.

LP:All claims are unsupported by the unreadable source.

LP:Family offices may also consider passive LP commitments in funds targeting life sciences investments in Houston.

LP:The passive LP angle for a family office involves committing capital to a life sciences fund managed by a seasoned sponsor.

LP:The passive LP angle for a family office would involve committing capital to a life sciences fund managed by a reputable sponsor.

LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure without direct management responsibilities.

LP:As a passive LP, a family office could commit capital to funds focused on life sciences, benefiting from the sector's growth without direct operational involvement.

LP:Family offices can also consider passive LP commitments in established life sciences funds to gain exposure without direct management responsibilities.

LP:As a passive LP, a family office could commit to funds focused on life sciences, though this approach may limit direct influence over asset management.

LP:As a passive LP, a family office could commit to a fund focused on life science investments, benefiting from the expertise of established sponsors.

LP:As a passive LP, a family office could commit to funds focused on life sciences, gaining exposure to the sector without direct operational involvement.

LP:The passive LP angle for a family office would involve committing capital to a fund focused on life sciences investments in the region.

LP:Family offices can also consider passive LP commitments in funds focused on life sciences to gain exposure without direct management responsibilities.

LP:Family offices may also consider passive LP commitments in life sciences funds to gain exposure without operational involvement.

LP:The passive LP angle for a family office could involve committing to funds focused on life sciences real estate, leveraging the expertise of established sponsors.

LP:As a passive LP, a family office could commit to funds focused on life sciences, gaining exposure to the sector without direct management responsibilities.

LP:Family offices may also consider passive LP commitments in funds focused on life sciences to gain exposure without direct operational involvement.